Literature DB >> 7481568

Expectations and motives for substance use in schizophrenia.

K T Mueser1, P Nishith, J I Tracy, J DeGirolamo, M Molinaro.   

Abstract

This study examined the internal reliability of standardized measures of substance use expectancies and motives in a schizophrenia population (n = 70) and the relationship of these expectancies and motives to alcohol and drug use disorders. Internal reliabilities were uniformly high for the subscales of the expectancy and motive measures. Analyses of the relationship between substance use disorders and expectancies revealed strong substance-specific expectations. Alcohol expectancies were related to alcohol disorders but not to drug disorders; cocaine expectancies were related to drug but not to alcohol disorders; and marijuana expectancies were more strongly related to drug than to alcohol use disorders. In contrast, motives were related to substance use disorders, and self-reported substance use problems were related to expectancies and motives in a non-specific manner. These results suggest that expectancy and motive questionnaires developed for the primary substance abuse population may be valid for psychiatric populations. Research on motives and expectancies may help to clarify the functions of substance abuse in persons with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7481568     DOI: 10.1093/schbul/21.3.367

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  13 in total

1.  A family intervention program for dual disorders.

Authors:  Kim T Mueser; Lindy Fox
Journal:  Community Ment Health J       Date:  2002-06

2.  A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence.

Authors:  Michael W Otto; Bridget A Hearon; R Kathryn McHugh; Amanda W Calkins; Elizabeth Pratt; Heather W Murray; Steven A Safren; Mark H Pollack
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

3.  The role of perceived belongingness to a drug subculture among opioid-dependent patients.

Authors:  Samantha J Moshier; R Kathryn McHugh; Amanda W Calkins; Bridget A Hearon; Anthony J Rosellini; Meara L Weitzman; Michael W Otto
Journal:  Psychol Addict Behav       Date:  2012-06-25

4.  It depends on when you ask: motives for using marijuana assessed before versus after a marijuana use event.

Authors:  Lydia A Shrier; Emily Blood Scherer
Journal:  Addict Behav       Date:  2014-07-18       Impact factor: 3.913

Review 5.  The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.

Authors:  John H Krystal; D Cyril D'Souza; Jürgen Gallinat; Naomi Driesen; Anissa Abi-Dargham; Ismene Petrakis; Andreas Heinz; Godfrey Pearlson
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

6.  The Effectiveness of Supported Employment in People With Dual Disorders.

Authors:  Kim T Mueser; Kikuko Campbell; Robert E Drake
Journal:  J Dual Diagn       Date:  2011-05-11

Review 7.  The link between schizophrenia and substance use disorder: A unifying hypothesis.

Authors:  Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green
Journal:  Schizophr Res       Date:  2017-04-14       Impact factor: 4.939

8.  Prevalence of psychotic symptoms in substance users: a comparison across substances.

Authors:  Matthew J Smith; Jagadisha Thirthalli; Arbi Ben Abdallah; Robin M Murray; Linda B Cottler
Journal:  Compr Psychiatry       Date:  2008-09-23       Impact factor: 3.735

9.  Predictors of dropout from psychosocial treatment in opioid-dependent outpatients.

Authors:  R Kathryn McHugh; Heather W Murray; Bridget A Hearon; Elizabeth M Pratt; Mark H Pollack; Steven A Safren; Michael W Otto
Journal:  Am J Addict       Date:  2013-01

10.  Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use.

Authors:  R Kathryn McHugh; Victoria R Votaw; Nadine R Taghian; Margaret L Griffin; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2020-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.